Global Methotrexate Injection Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
It is used to treat leukemia and certain types of cancer of the breast, skin, head and neck, or lung.
LPI (LP Information)' newest research report, the “Methotrexate Injection Industry Forecast” looks at past sales and reviews total world Methotrexate Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Methotrexate Injection sales for 2023 through 2029. With Methotrexate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Methotrexate Injection industry.
This Insight Report provides a comprehensive analysis of the global Methotrexate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Methotrexate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Methotrexate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Methotrexate Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Methotrexate Injection.
The global Methotrexate Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Methotrexate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Methotrexate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Methotrexate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Methotrexate Injection players cover Hikma, Teva, Accord, Fresenius Kabi, Mylan, Pfizer, Get Well Pharmaceutical, Sichuan Huiyu Pharma and Youcare Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Methotrexate Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Methotrexate Injection market?
What factors are driving Methotrexate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Methotrexate Injection market opportunities vary by end market size?
How does Methotrexate Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
It is used to treat leukemia and certain types of cancer of the breast, skin, head and neck, or lung.
LPI (LP Information)' newest research report, the “Methotrexate Injection Industry Forecast” looks at past sales and reviews total world Methotrexate Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Methotrexate Injection sales for 2023 through 2029. With Methotrexate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Methotrexate Injection industry.
This Insight Report provides a comprehensive analysis of the global Methotrexate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Methotrexate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Methotrexate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Methotrexate Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Methotrexate Injection.
The global Methotrexate Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Methotrexate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Methotrexate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Methotrexate Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Methotrexate Injection players cover Hikma, Teva, Accord, Fresenius Kabi, Mylan, Pfizer, Get Well Pharmaceutical, Sichuan Huiyu Pharma and Youcare Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Methotrexate Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Preservative-Free
- With Preservative
- Hospital
- Specialty Clinic
- Recovry Center
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hikma
- Teva
- Accord
- Fresenius Kabi
- Mylan
- Pfizer
- Get Well Pharmaceutical
- Sichuan Huiyu Pharma
- Youcare Pharmaceutical Group
- Qilu Pharmaceutical
- Shanxi Pude Pharma
- Hengrui Medicine
- Guangdong Lingnan Pharma
What is the 10-year outlook for the global Methotrexate Injection market?
What factors are driving Methotrexate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Methotrexate Injection market opportunities vary by end market size?
How does Methotrexate Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Methotrexate Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Methotrexate Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Methotrexate Injection by Country/Region, 2018, 2022 & 2029
2.2 Methotrexate Injection Segment by Type
2.2.1 Preservative-Free
2.2.2 With Preservative
2.3 Methotrexate Injection Sales by Type
2.3.1 Global Methotrexate Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Methotrexate Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Methotrexate Injection Sale Price by Type (2018-2023)
2.4 Methotrexate Injection Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Recovry Center
2.5 Methotrexate Injection Sales by Application
2.5.1 Global Methotrexate Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Methotrexate Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Methotrexate Injection Sale Price by Application (2018-2023)
3 GLOBAL METHOTREXATE INJECTION BY COMPANY
3.1 Global Methotrexate Injection Breakdown Data by Company
3.1.1 Global Methotrexate Injection Annual Sales by Company (2018-2023)
3.1.2 Global Methotrexate Injection Sales Market Share by Company (2018-2023)
3.2 Global Methotrexate Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Methotrexate Injection Revenue by Company (2018-2023)
3.2.2 Global Methotrexate Injection Revenue Market Share by Company (2018-2023)
3.3 Global Methotrexate Injection Sale Price by Company
3.4 Key Manufacturers Methotrexate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Methotrexate Injection Product Location Distribution
3.4.2 Players Methotrexate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR METHOTREXATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Methotrexate Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Methotrexate Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Methotrexate Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Methotrexate Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Methotrexate Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Methotrexate Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Methotrexate Injection Sales Growth
4.4 APAC Methotrexate Injection Sales Growth
4.5 Europe Methotrexate Injection Sales Growth
4.6 Middle East & Africa Methotrexate Injection Sales Growth
5 AMERICAS
5.1 Americas Methotrexate Injection Sales by Country
5.1.1 Americas Methotrexate Injection Sales by Country (2018-2023)
5.1.2 Americas Methotrexate Injection Revenue by Country (2018-2023)
5.2 Americas Methotrexate Injection Sales by Type
5.3 Americas Methotrexate Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Methotrexate Injection Sales by Region
6.1.1 APAC Methotrexate Injection Sales by Region (2018-2023)
6.1.2 APAC Methotrexate Injection Revenue by Region (2018-2023)
6.2 APAC Methotrexate Injection Sales by Type
6.3 APAC Methotrexate Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Methotrexate Injection by Country
7.1.1 Europe Methotrexate Injection Sales by Country (2018-2023)
7.1.2 Europe Methotrexate Injection Revenue by Country (2018-2023)
7.2 Europe Methotrexate Injection Sales by Type
7.3 Europe Methotrexate Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Methotrexate Injection by Country
8.1.1 Middle East & Africa Methotrexate Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Methotrexate Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Methotrexate Injection Sales by Type
8.3 Middle East & Africa Methotrexate Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Methotrexate Injection
10.3 Manufacturing Process Analysis of Methotrexate Injection
10.4 Industry Chain Structure of Methotrexate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Methotrexate Injection Distributors
11.3 Methotrexate Injection Customer
12 WORLD FORECAST REVIEW FOR METHOTREXATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Methotrexate Injection Market Size Forecast by Region
12.1.1 Global Methotrexate Injection Forecast by Region (2024-2029)
12.1.2 Global Methotrexate Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Methotrexate Injection Forecast by Type
12.7 Global Methotrexate Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hikma
13.1.1 Hikma Company Information
13.1.2 Hikma Methotrexate Injection Product Portfolios and Specifications
13.1.3 Hikma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hikma Main Business Overview
13.1.5 Hikma Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Methotrexate Injection Product Portfolios and Specifications
13.2.3 Teva Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Accord
13.3.1 Accord Company Information
13.3.2 Accord Methotrexate Injection Product Portfolios and Specifications
13.3.3 Accord Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Accord Main Business Overview
13.3.5 Accord Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Methotrexate Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Methotrexate Injection Product Portfolios and Specifications
13.5.3 Mylan Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Methotrexate Injection Product Portfolios and Specifications
13.6.3 Pfizer Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Get Well Pharmaceutical
13.7.1 Get Well Pharmaceutical Company Information
13.7.2 Get Well Pharmaceutical Methotrexate Injection Product Portfolios and Specifications
13.7.3 Get Well Pharmaceutical Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Get Well Pharmaceutical Main Business Overview
13.7.5 Get Well Pharmaceutical Latest Developments
13.8 Sichuan Huiyu Pharma
13.8.1 Sichuan Huiyu Pharma Company Information
13.8.2 Sichuan Huiyu Pharma Methotrexate Injection Product Portfolios and Specifications
13.8.3 Sichuan Huiyu Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sichuan Huiyu Pharma Main Business Overview
13.8.5 Sichuan Huiyu Pharma Latest Developments
13.9 Youcare Pharmaceutical Group
13.9.1 Youcare Pharmaceutical Group Company Information
13.9.2 Youcare Pharmaceutical Group Methotrexate Injection Product Portfolios and Specifications
13.9.3 Youcare Pharmaceutical Group Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Youcare Pharmaceutical Group Main Business Overview
13.9.5 Youcare Pharmaceutical Group Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Methotrexate Injection Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
13.11 Shanxi Pude Pharma
13.11.1 Shanxi Pude Pharma Company Information
13.11.2 Shanxi Pude Pharma Methotrexate Injection Product Portfolios and Specifications
13.11.3 Shanxi Pude Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanxi Pude Pharma Main Business Overview
13.11.5 Shanxi Pude Pharma Latest Developments
13.12 Hengrui Medicine
13.12.1 Hengrui Medicine Company Information
13.12.2 Hengrui Medicine Methotrexate Injection Product Portfolios and Specifications
13.12.3 Hengrui Medicine Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hengrui Medicine Main Business Overview
13.12.5 Hengrui Medicine Latest Developments
13.13 Guangdong Lingnan Pharma
13.13.1 Guangdong Lingnan Pharma Company Information
13.13.2 Guangdong Lingnan Pharma Methotrexate Injection Product Portfolios and Specifications
13.13.3 Guangdong Lingnan Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Guangdong Lingnan Pharma Main Business Overview
13.13.5 Guangdong Lingnan Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Methotrexate Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Methotrexate Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Methotrexate Injection by Country/Region, 2018, 2022 & 2029
2.2 Methotrexate Injection Segment by Type
2.2.1 Preservative-Free
2.2.2 With Preservative
2.3 Methotrexate Injection Sales by Type
2.3.1 Global Methotrexate Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Methotrexate Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Methotrexate Injection Sale Price by Type (2018-2023)
2.4 Methotrexate Injection Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Recovry Center
2.5 Methotrexate Injection Sales by Application
2.5.1 Global Methotrexate Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Methotrexate Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Methotrexate Injection Sale Price by Application (2018-2023)
3 GLOBAL METHOTREXATE INJECTION BY COMPANY
3.1 Global Methotrexate Injection Breakdown Data by Company
3.1.1 Global Methotrexate Injection Annual Sales by Company (2018-2023)
3.1.2 Global Methotrexate Injection Sales Market Share by Company (2018-2023)
3.2 Global Methotrexate Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Methotrexate Injection Revenue by Company (2018-2023)
3.2.2 Global Methotrexate Injection Revenue Market Share by Company (2018-2023)
3.3 Global Methotrexate Injection Sale Price by Company
3.4 Key Manufacturers Methotrexate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Methotrexate Injection Product Location Distribution
3.4.2 Players Methotrexate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR METHOTREXATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Methotrexate Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Methotrexate Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Methotrexate Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Methotrexate Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Methotrexate Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Methotrexate Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Methotrexate Injection Sales Growth
4.4 APAC Methotrexate Injection Sales Growth
4.5 Europe Methotrexate Injection Sales Growth
4.6 Middle East & Africa Methotrexate Injection Sales Growth
5 AMERICAS
5.1 Americas Methotrexate Injection Sales by Country
5.1.1 Americas Methotrexate Injection Sales by Country (2018-2023)
5.1.2 Americas Methotrexate Injection Revenue by Country (2018-2023)
5.2 Americas Methotrexate Injection Sales by Type
5.3 Americas Methotrexate Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Methotrexate Injection Sales by Region
6.1.1 APAC Methotrexate Injection Sales by Region (2018-2023)
6.1.2 APAC Methotrexate Injection Revenue by Region (2018-2023)
6.2 APAC Methotrexate Injection Sales by Type
6.3 APAC Methotrexate Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Methotrexate Injection by Country
7.1.1 Europe Methotrexate Injection Sales by Country (2018-2023)
7.1.2 Europe Methotrexate Injection Revenue by Country (2018-2023)
7.2 Europe Methotrexate Injection Sales by Type
7.3 Europe Methotrexate Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Methotrexate Injection by Country
8.1.1 Middle East & Africa Methotrexate Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Methotrexate Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Methotrexate Injection Sales by Type
8.3 Middle East & Africa Methotrexate Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Methotrexate Injection
10.3 Manufacturing Process Analysis of Methotrexate Injection
10.4 Industry Chain Structure of Methotrexate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Methotrexate Injection Distributors
11.3 Methotrexate Injection Customer
12 WORLD FORECAST REVIEW FOR METHOTREXATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Methotrexate Injection Market Size Forecast by Region
12.1.1 Global Methotrexate Injection Forecast by Region (2024-2029)
12.1.2 Global Methotrexate Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Methotrexate Injection Forecast by Type
12.7 Global Methotrexate Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hikma
13.1.1 Hikma Company Information
13.1.2 Hikma Methotrexate Injection Product Portfolios and Specifications
13.1.3 Hikma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hikma Main Business Overview
13.1.5 Hikma Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Methotrexate Injection Product Portfolios and Specifications
13.2.3 Teva Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Accord
13.3.1 Accord Company Information
13.3.2 Accord Methotrexate Injection Product Portfolios and Specifications
13.3.3 Accord Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Accord Main Business Overview
13.3.5 Accord Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Methotrexate Injection Product Portfolios and Specifications
13.4.3 Fresenius Kabi Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Methotrexate Injection Product Portfolios and Specifications
13.5.3 Mylan Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Methotrexate Injection Product Portfolios and Specifications
13.6.3 Pfizer Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Get Well Pharmaceutical
13.7.1 Get Well Pharmaceutical Company Information
13.7.2 Get Well Pharmaceutical Methotrexate Injection Product Portfolios and Specifications
13.7.3 Get Well Pharmaceutical Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Get Well Pharmaceutical Main Business Overview
13.7.5 Get Well Pharmaceutical Latest Developments
13.8 Sichuan Huiyu Pharma
13.8.1 Sichuan Huiyu Pharma Company Information
13.8.2 Sichuan Huiyu Pharma Methotrexate Injection Product Portfolios and Specifications
13.8.3 Sichuan Huiyu Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sichuan Huiyu Pharma Main Business Overview
13.8.5 Sichuan Huiyu Pharma Latest Developments
13.9 Youcare Pharmaceutical Group
13.9.1 Youcare Pharmaceutical Group Company Information
13.9.2 Youcare Pharmaceutical Group Methotrexate Injection Product Portfolios and Specifications
13.9.3 Youcare Pharmaceutical Group Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Youcare Pharmaceutical Group Main Business Overview
13.9.5 Youcare Pharmaceutical Group Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Methotrexate Injection Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
13.11 Shanxi Pude Pharma
13.11.1 Shanxi Pude Pharma Company Information
13.11.2 Shanxi Pude Pharma Methotrexate Injection Product Portfolios and Specifications
13.11.3 Shanxi Pude Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanxi Pude Pharma Main Business Overview
13.11.5 Shanxi Pude Pharma Latest Developments
13.12 Hengrui Medicine
13.12.1 Hengrui Medicine Company Information
13.12.2 Hengrui Medicine Methotrexate Injection Product Portfolios and Specifications
13.12.3 Hengrui Medicine Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hengrui Medicine Main Business Overview
13.12.5 Hengrui Medicine Latest Developments
13.13 Guangdong Lingnan Pharma
13.13.1 Guangdong Lingnan Pharma Company Information
13.13.2 Guangdong Lingnan Pharma Methotrexate Injection Product Portfolios and Specifications
13.13.3 Guangdong Lingnan Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Guangdong Lingnan Pharma Main Business Overview
13.13.5 Guangdong Lingnan Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Methotrexate Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Methotrexate Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Preservative-Free
Table 4. Major Players of With Preservative
Table 5. Global Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Methotrexate Injection Sales Market Share by Type (2018-2023)
Table 7. Global Methotrexate Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Methotrexate Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Methotrexate Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Methotrexate Injection Sales Market Share by Application (2018-2023)
Table 12. Global Methotrexate Injection Revenue by Application (2018-2023)
Table 13. Global Methotrexate Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Methotrexate Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Methotrexate Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Methotrexate Injection Sales Market Share by Company (2018-2023)
Table 17. Global Methotrexate Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Methotrexate Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Methotrexate Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Methotrexate Injection Producing Area Distribution and Sales Area
Table 21. Players Methotrexate Injection Products Offered
Table 22. Methotrexate Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Methotrexate Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Methotrexate Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Methotrexate Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Methotrexate Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Methotrexate Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Methotrexate Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Methotrexate Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Methotrexate Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Methotrexate Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Methotrexate Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Methotrexate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Methotrexate Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Methotrexate Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Methotrexate Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Methotrexate Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Methotrexate Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Methotrexate Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Methotrexate Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Methotrexate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Methotrexate Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Methotrexate Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Methotrexate Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Methotrexate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Methotrexate Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Methotrexate Injection
Table 58. Key Market Challenges & Risks of Methotrexate Injection
Table 59. Key Industry Trends of Methotrexate Injection
Table 60. Methotrexate Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Methotrexate Injection Distributors List
Table 63. Methotrexate Injection Customer List
Table 64. Global Methotrexate Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Methotrexate Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Methotrexate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Methotrexate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Methotrexate Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Methotrexate Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Methotrexate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Methotrexate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Methotrexate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Methotrexate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Methotrexate Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Methotrexate Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Methotrexate Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Methotrexate Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Hikma Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Hikma Methotrexate Injection Product Portfolios and Specifications
Table 80. Hikma Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Hikma Main Business
Table 82. Hikma Latest Developments
Table 83. Teva Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Methotrexate Injection Product Portfolios and Specifications
Table 85. Teva Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Accord Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Accord Methotrexate Injection Product Portfolios and Specifications
Table 90. Accord Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Accord Main Business
Table 92. Accord Latest Developments
Table 93. Fresenius Kabi Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Fresenius Kabi Methotrexate Injection Product Portfolios and Specifications
Table 95. Fresenius Kabi Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Fresenius Kabi Main Business
Table 97. Fresenius Kabi Latest Developments
Table 98. Mylan Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Methotrexate Injection Product Portfolios and Specifications
Table 100. Mylan Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Mylan Main Business
Table 102. Mylan Latest Developments
Table 103. Pfizer Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Methotrexate Injection Product Portfolios and Specifications
Table 105. Pfizer Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Get Well Pharmaceutical Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Get Well Pharmaceutical Methotrexate Injection Product Portfolios and Specifications
Table 110. Get Well Pharmaceutical Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Get Well Pharmaceutical Main Business
Table 112. Get Well Pharmaceutical Latest Developments
Table 113. Sichuan Huiyu Pharma Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Sichuan Huiyu Pharma Methotrexate Injection Product Portfolios and Specifications
Table 115. Sichuan Huiyu Pharma Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sichuan Huiyu Pharma Main Business
Table 117. Sichuan Huiyu Pharma Latest Developments
Table 118. Youcare Pharmaceutical Group Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Youcare Pharmaceutical Group Methotrexate Injection Product Portfolios and Specifications
Table 120. Youcare Pharmaceutical Group Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Youcare Pharmaceutical Group Main Business
Table 122. Youcare Pharmaceutical Group Latest Developments
Table 123. Qilu Pharmaceutical Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Qilu Pharmaceutical Methotrexate Injection Product Portfolios and Specifications
Table 125. Qilu Pharmaceutical Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Qilu Pharmaceutical Main Business
Table 127. Qilu Pharmaceutical Latest Developments
Table 128. Shanxi Pude Pharma Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanxi Pude Pharma Methotrexate Injection Product Portfolios and Specifications
Table 130. Shanxi Pude Pharma Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Shanxi Pude Pharma Main Business
Table 132. Shanxi Pude Pharma Latest Developments
Table 133. Hengrui Medicine Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Hengrui Medicine Methotrexate Injection Product Portfolios and Specifications
Table 135. Hengrui Medicine Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Hengrui Medicine Main Business
Table 137. Hengrui Medicine Latest Developments
Table 138. Guangdong Lingnan Pharma Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Guangdong Lingnan Pharma Methotrexate Injection Product Portfolios and Specifications
Table 140. Guangdong Lingnan Pharma Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Guangdong Lingnan Pharma Main Business
Table 142. Guangdong Lingnan Pharma Latest Developments
Table 1. Methotrexate Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Methotrexate Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Preservative-Free
Table 4. Major Players of With Preservative
Table 5. Global Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Methotrexate Injection Sales Market Share by Type (2018-2023)
Table 7. Global Methotrexate Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Methotrexate Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Methotrexate Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Methotrexate Injection Sales Market Share by Application (2018-2023)
Table 12. Global Methotrexate Injection Revenue by Application (2018-2023)
Table 13. Global Methotrexate Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Methotrexate Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Methotrexate Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Methotrexate Injection Sales Market Share by Company (2018-2023)
Table 17. Global Methotrexate Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Methotrexate Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Methotrexate Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Methotrexate Injection Producing Area Distribution and Sales Area
Table 21. Players Methotrexate Injection Products Offered
Table 22. Methotrexate Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Methotrexate Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Methotrexate Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Methotrexate Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Methotrexate Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Methotrexate Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Methotrexate Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Methotrexate Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Methotrexate Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Methotrexate Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Methotrexate Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Methotrexate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Methotrexate Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Methotrexate Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Methotrexate Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Methotrexate Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Methotrexate Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Methotrexate Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Methotrexate Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Methotrexate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Methotrexate Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Methotrexate Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Methotrexate Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Methotrexate Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Methotrexate Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Methotrexate Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Methotrexate Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Methotrexate Injection
Table 58. Key Market Challenges & Risks of Methotrexate Injection
Table 59. Key Industry Trends of Methotrexate Injection
Table 60. Methotrexate Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Methotrexate Injection Distributors List
Table 63. Methotrexate Injection Customer List
Table 64. Global Methotrexate Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Methotrexate Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Methotrexate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Methotrexate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Methotrexate Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Methotrexate Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Methotrexate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Methotrexate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Methotrexate Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Methotrexate Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Methotrexate Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Methotrexate Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Methotrexate Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Methotrexate Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Hikma Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Hikma Methotrexate Injection Product Portfolios and Specifications
Table 80. Hikma Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Hikma Main Business
Table 82. Hikma Latest Developments
Table 83. Teva Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Methotrexate Injection Product Portfolios and Specifications
Table 85. Teva Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Accord Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Accord Methotrexate Injection Product Portfolios and Specifications
Table 90. Accord Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Accord Main Business
Table 92. Accord Latest Developments
Table 93. Fresenius Kabi Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Fresenius Kabi Methotrexate Injection Product Portfolios and Specifications
Table 95. Fresenius Kabi Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Fresenius Kabi Main Business
Table 97. Fresenius Kabi Latest Developments
Table 98. Mylan Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Methotrexate Injection Product Portfolios and Specifications
Table 100. Mylan Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Mylan Main Business
Table 102. Mylan Latest Developments
Table 103. Pfizer Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Methotrexate Injection Product Portfolios and Specifications
Table 105. Pfizer Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Get Well Pharmaceutical Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Get Well Pharmaceutical Methotrexate Injection Product Portfolios and Specifications
Table 110. Get Well Pharmaceutical Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Get Well Pharmaceutical Main Business
Table 112. Get Well Pharmaceutical Latest Developments
Table 113. Sichuan Huiyu Pharma Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Sichuan Huiyu Pharma Methotrexate Injection Product Portfolios and Specifications
Table 115. Sichuan Huiyu Pharma Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sichuan Huiyu Pharma Main Business
Table 117. Sichuan Huiyu Pharma Latest Developments
Table 118. Youcare Pharmaceutical Group Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Youcare Pharmaceutical Group Methotrexate Injection Product Portfolios and Specifications
Table 120. Youcare Pharmaceutical Group Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Youcare Pharmaceutical Group Main Business
Table 122. Youcare Pharmaceutical Group Latest Developments
Table 123. Qilu Pharmaceutical Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Qilu Pharmaceutical Methotrexate Injection Product Portfolios and Specifications
Table 125. Qilu Pharmaceutical Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Qilu Pharmaceutical Main Business
Table 127. Qilu Pharmaceutical Latest Developments
Table 128. Shanxi Pude Pharma Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanxi Pude Pharma Methotrexate Injection Product Portfolios and Specifications
Table 130. Shanxi Pude Pharma Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Shanxi Pude Pharma Main Business
Table 132. Shanxi Pude Pharma Latest Developments
Table 133. Hengrui Medicine Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Hengrui Medicine Methotrexate Injection Product Portfolios and Specifications
Table 135. Hengrui Medicine Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Hengrui Medicine Main Business
Table 137. Hengrui Medicine Latest Developments
Table 138. Guangdong Lingnan Pharma Basic Information, Methotrexate Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Guangdong Lingnan Pharma Methotrexate Injection Product Portfolios and Specifications
Table 140. Guangdong Lingnan Pharma Methotrexate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Guangdong Lingnan Pharma Main Business
Table 142. Guangdong Lingnan Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Methotrexate Injection
Figure 2. Methotrexate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Methotrexate Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Methotrexate Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Methotrexate Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Preservative-Free
Figure 10. Product Picture of With Preservative
Figure 11. Global Methotrexate Injection Sales Market Share by Type in 2022
Figure 12. Global Methotrexate Injection Revenue Market Share by Type (2018-2023)
Figure 13. Methotrexate Injection Consumed in Hospital
Figure 14. Global Methotrexate Injection Market: Hospital (2018-2023) & (K Units)
Figure 15. Methotrexate Injection Consumed in Specialty Clinic
Figure 16. Global Methotrexate Injection Market: Specialty Clinic (2018-2023) & (K Units)
Figure 17. Methotrexate Injection Consumed in Recovry Center
Figure 18. Global Methotrexate Injection Market: Recovry Center (2018-2023) & (K Units)
Figure 19. Global Methotrexate Injection Sales Market Share by Application (2022)
Figure 20. Global Methotrexate Injection Revenue Market Share by Application in 2022
Figure 21. Methotrexate Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Methotrexate Injection Sales Market Share by Company in 2022
Figure 23. Methotrexate Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Methotrexate Injection Revenue Market Share by Company in 2022
Figure 25. Global Methotrexate Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Methotrexate Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Methotrexate Injection Sales 2018-2023 (K Units)
Figure 28. Americas Methotrexate Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Methotrexate Injection Sales 2018-2023 (K Units)
Figure 30. APAC Methotrexate Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Methotrexate Injection Sales 2018-2023 (K Units)
Figure 32. Europe Methotrexate Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Methotrexate Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Methotrexate Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Methotrexate Injection Sales Market Share by Country in 2022
Figure 36. Americas Methotrexate Injection Revenue Market Share by Country in 2022
Figure 37. Americas Methotrexate Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Methotrexate Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Methotrexate Injection Sales Market Share by Region in 2022
Figure 44. APAC Methotrexate Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Methotrexate Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Methotrexate Injection Sales Market Share by Application (2018-2023)
Figure 47. China Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Methotrexate Injection Sales Market Share by Country in 2022
Figure 55. Europe Methotrexate Injection Revenue Market Share by Country in 2022
Figure 56. Europe Methotrexate Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Methotrexate Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Methotrexate Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Methotrexate Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Methotrexate Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Methotrexate Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Methotrexate Injection in 2022
Figure 73. Manufacturing Process Analysis of Methotrexate Injection
Figure 74. Industry Chain Structure of Methotrexate Injection
Figure 75. Channels of Distribution
Figure 76. Global Methotrexate Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Methotrexate Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Methotrexate Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Methotrexate Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Methotrexate Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Methotrexate Injection Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Methotrexate Injection
Figure 2. Methotrexate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Methotrexate Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Methotrexate Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Methotrexate Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Preservative-Free
Figure 10. Product Picture of With Preservative
Figure 11. Global Methotrexate Injection Sales Market Share by Type in 2022
Figure 12. Global Methotrexate Injection Revenue Market Share by Type (2018-2023)
Figure 13. Methotrexate Injection Consumed in Hospital
Figure 14. Global Methotrexate Injection Market: Hospital (2018-2023) & (K Units)
Figure 15. Methotrexate Injection Consumed in Specialty Clinic
Figure 16. Global Methotrexate Injection Market: Specialty Clinic (2018-2023) & (K Units)
Figure 17. Methotrexate Injection Consumed in Recovry Center
Figure 18. Global Methotrexate Injection Market: Recovry Center (2018-2023) & (K Units)
Figure 19. Global Methotrexate Injection Sales Market Share by Application (2022)
Figure 20. Global Methotrexate Injection Revenue Market Share by Application in 2022
Figure 21. Methotrexate Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Methotrexate Injection Sales Market Share by Company in 2022
Figure 23. Methotrexate Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Methotrexate Injection Revenue Market Share by Company in 2022
Figure 25. Global Methotrexate Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Methotrexate Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Methotrexate Injection Sales 2018-2023 (K Units)
Figure 28. Americas Methotrexate Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Methotrexate Injection Sales 2018-2023 (K Units)
Figure 30. APAC Methotrexate Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Methotrexate Injection Sales 2018-2023 (K Units)
Figure 32. Europe Methotrexate Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Methotrexate Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Methotrexate Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Methotrexate Injection Sales Market Share by Country in 2022
Figure 36. Americas Methotrexate Injection Revenue Market Share by Country in 2022
Figure 37. Americas Methotrexate Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Methotrexate Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Methotrexate Injection Sales Market Share by Region in 2022
Figure 44. APAC Methotrexate Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Methotrexate Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Methotrexate Injection Sales Market Share by Application (2018-2023)
Figure 47. China Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Methotrexate Injection Sales Market Share by Country in 2022
Figure 55. Europe Methotrexate Injection Revenue Market Share by Country in 2022
Figure 56. Europe Methotrexate Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Methotrexate Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Methotrexate Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Methotrexate Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Methotrexate Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Methotrexate Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Methotrexate Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Methotrexate Injection in 2022
Figure 73. Manufacturing Process Analysis of Methotrexate Injection
Figure 74. Industry Chain Structure of Methotrexate Injection
Figure 75. Channels of Distribution
Figure 76. Global Methotrexate Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Methotrexate Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Methotrexate Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Methotrexate Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Methotrexate Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Methotrexate Injection Revenue Market Share Forecast by Application (2024-2029)
